Cabozantinib (C) in combination with atezolizumab (A) in non-clear cell renal cell carcinoma (nccRCC): Results from cohort 10 of the COSMIC-021 study
- Resource Type
- Journal
- Source
ANNALS OF ONCOLOGY ; SEP 2020, 31 pS558-pS558, 1p. Supplement: 4- Subject
- Language
- English
- ISSN
- 15698041